Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia

Table 3

Sperm parameters of the three examined groups before and after the hormonal treatment.

Parameters	Group A; (𝑛=20 patients)	Group B; (𝑛=20 patients)	Group C; (𝑛=14 patients)
Sperm parameters before treatment
Density (mil/mL)	6.6 ± 3.3	8.4 ± 5.7	7.7 ± 4.2
Normal forms (%)	2.2 ± 2.3	2.6 ± 1.3	1.9 ± 1.2
Progressive motility (%)	11.0 ± 6.0	14.0 ± 4.0	10.0 ± 7.0
Spermatids (%)	12.0 ± 6.0	14.0 ± 4.0	11.0 ± 4.0
Leukocytes (mil/mL)	0.4 ± 0.3	0.6 ± 0.3	0.3 ± 0.2
CD45pos cells (mil/mL)	1.8 ± 1.2	1.5 ± 1.4	1.7 ± 1.3
Sperm parameters after treatment
Density (mil/mL)	8.8 ± 4.2	10.8 ± 4.6	9.0 ± 3.0
Normal forms (%)	4.2 ± 2.8*	5.0 ± 1.7*	3.6 ± 1.6*
Progressive motility (%)	14.0 ± 8.0	19.0 ± 3.0	15.0 ± 6.0
Spermatids (%)	4.0 ± 2.0*	5.0 ± 3.0*	3.0 ± 2.0*
Leukocytes (mil/mL)	0.2 ± 0.2	0.4 ± 0.2	0.2 ± 0.3
CD45pos cells (mil/mL)	0.5 ± 0.2*	0.4 ± 0.3*	0.4 ± 0.2*

^∗𝑃<0.05 versus baseline.